Clinical Trial Update: Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of oral idebenone for non-alcoholic steatohepatitis with fibrosis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Non-alcoholic Steatohepatitis

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: Stanford University | Conditions: Non Alcoholic Steatohepatitis, Fibrosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-03-27